Search All News
The HPV vaccine has great potential to reduce the rate of cervical cancer in Africa, where Columbia researchers are trying to increase vaccination rates with texts.
Mailman experts and other policymakers discuss measures that should be deployed during vaccine rollout to reduce inequities, already worsened by the pandemic, in the U.S. and globally.
Wafaa El-Sadr, MD, MPH, will serve as the next director of Columbia World Projects, an initiative focused on bringing Columbia's academic resources to bear on the great challenges facing humanity.
Mailman's ICAP has harnessed the partnerships made in combating HIV in Africa, Asia, and the Americas to meet the threat of COVID-19.
- August 7, 2020
A treatment that prevents an often-fatal disease in fetuses and newborns only reaches half of the pregnant women around the world who need it, Columbia researchers have found.
- July 22, 2020
The International Collaboration and Exchange Program convenes premedical, medical, and dental students from Columbia University and beyond to discuss their COVID-19 experiences via online coursework.
- January 9, 2020
Researchers hoped treatment of HIV-infected infants within hours of birth would increase remission, but a new study finds that starting treatment within the first two weeks leads to similar outcomes.
- November 7, 2018
ICAP launched the world’s first multi-country HIV treatment program in 2003 and has helped bring life-saving treatment to nearly 1.5 million people in resource-poor regions around the world.
- August 28, 2018
The first-line treatment for malaria in no longer effective in Cambodia, and a new report from Columbia researchers has identified the likely culprit.
- April 6, 2018
With a new grant from the U.S. President’s Malaria Initiative, Mailman’s ICAP will support the implementation of quality malaria diagnosis and treatment services in Ethiopia.
- March 6, 2018
The working group will help Columbia scientists and physicians make their expertise available to policymakers involved in global health security.
- November 8, 2017
New Zika research from Columbia University suggests that high rates of microcephaly in Brazil were not caused by new mutations in the virus, as previously believed.